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combination with hypothermia or normothermia. In
addition, it has also been used to preserve the donor
heart under hypothermia for transplantation. During the
cardioplegic arrest, coronary vascular endothelium is in
direct contact with this solution. Therefore an important
issue is whether STS affects endothelial cells and, sub-
sequently, causes the change of coronary vascular reac-
tivity. Several previous studies have focused on the
preservation of myocardial function in evaluating the
efficacy of this cardioplegic solution.1,2 In addition,
attention has been paid to the effect of this solution on
coronary endothelial function.3,4
Vascular endothelium plays a key control role in the
regulation of vascular tone through releasing diverse
vasoactive substances. Among those, endothelium-
derived relaxing factors (EDRFs) are responsible for
endothelium-dependent relaxation.5 The major compo-
S t Thomas’ Hospital solution (STS) has been inwidespread clinical use to arrest the heart for pre-
cise intracardiac reconstruction or coronary grafting in
Objectives: We examined the effect of St Thomas’ Hospital solution on
endothelium-derived hyperpolarizing factor–mediated function in the
porcine coronary microarteries with emphasis on the effect of tempera-
ture and washout time. Methods: Microartery rings (diameter, 200-450
µm) were studied in myograph. The arteries were incubated in St
Thomas’ Hospital or Krebs solution (control) at 4°C for 4 hours fol-
lowed by 45 minutes (group Ia) or 90 minutes washout (group Ib) or at
22°C for 1 hour followed by 45 minutes (group IIa) or 90 minutes
washout (group IIb) and precontracted with –8.5 log M U46619. The
endothelium-derived hyperpolarizing factor–mediated relaxation to
bradykinin was studied when endothelium-derived nitric oxide and
prostaglandin I2 were inhibited with the presence of 7 µmol/L
indomethacin and 300 µmol/L NG-nitro-L-arginine. Results: After expo-
sure to St Thomas’ Hospital solution, the maximal endothelium-derived
hyperpolarizing factor–mediated relaxation (percentage of the precon-
traction) was significantly reduced at either temperature after washout
for 45 minutes (group Ia, 42.7% ± 3.5% vs 69.0% ± 5.3%; n = 9; P =
.000; and group IIa, 12.3% ± 1.6% vs 56.1% ± 4.4%; n = 8; P = .000)
but fully recovered after washout for 90 minutes. The U46619-induced
contraction force was also significantly reduced after washout for 45
minutes (P < .001) but fully recovered at 90 minutes. Conclusions: Under
profound and moderate hypothermia, St Thomas’ Hospital solution
impairs endothelium-derived hyperpolarizing factor–mediated relax-
ation and smooth muscle contraction in the coronary microarteries.
These effects exist during the reperfusion period for at least 45 minutes
after exposure to St Thomas’ Hospital solution and may account for the
possible myocardial dysfunction during reperfusion. (J Thorac
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ALTERED ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR–MEDIATED ENDOTHELIAL 
FUNCTION IN CORONARY MICROARTERIES BY ST THOMAS’ HOSPITAL SOLUTION
nents of EDRFs have been shown to be endothelium-
derived nitric oxide (EDNO), epoprostenol (prostacy-
clin [PGI2]), and endothelium-derived hyperpolarizing
factor (EDHF).6,7 It is generally considered that EDHF
plays a significant role in the regulation of microvascu-
lature and thus of blood flow distribution.8 Because the
coronary microvascular system plays the key role in the
regulation of myocardial perfusion, the investigation on
the effect of STS on EDHF-mediated function in the
coronary microvascular system is particularly impor-
tant during cardioplegic arrest.9 However, this has not
been studied.
Potassium (K+) at high concentrations (hyper-
kalemia) is a known vascular irritant.10,11 Hyper-
kalemia has been shown to damage endothelium-
dependent relaxation.4,12,13 In those studies, the K+
concentrations ranged from 16 to 125 mmol/L.
Recently, we have performed a series of experiments
that show that hyperkalemia impairs EDHF-mediated
endothelial function in large conduit coronary arter-
ies.7,14-16 However, the components of STS are com-
plex; the effect of other components in STS, such as
magnesium and procaine, and the effect of STS as a
whole remain unknown. Further, the previous studies
regarding the effect of hyperkalemia on the EDHF-
mediated function were performed in large coronary
arteries and whether this is true in the more important
resistant arteries (microarteries) is unknown.
In addition, 2 other factors (ie, temperature and
washout time) may also affect the possible effect of
STS on the endothelial function.
The present study was therefore designed to examine
the effect of STS on EDHF-mediated endothelial func-
tion when the EDNO and PGI2 were inhibited by spe-
cific inhibitors in porcine coronary microarteries, with
emphasis on the effect of temperature and washout time.
Materials and methods
Arterial preparation and mounting. Fresh porcine hearts
collected from a local slaughterhouse were placed in a con-
tainer filled with cold Krebs solution and immediately trans-
ferred to the laboratory. The transportation time varied from
1 to 2 hours. On receipt of the heart, intramyocardial coro-
nary arteries (usually the tertiary branches of the left anterior
descending artery) in diameter of 200 to 450 m m at pressure
of 100 mm Hg were carefully dissected out, with care taken
to protect the endothelium. The vessel was cleaned of fat and
connective tissue and cut into cylindric rings of 2 mm long
under a microscope. The ring was guided a suitable length
through its lumen by a pair of stainless steel wires (40 m m in
diameter). One wire was fixed tightly on a jaw in a 2-channel
myograph (model 500A; J P Trading, Aarhus, Denmark),17
and another wire was passed lightly through the vascular
lumen and anchored another jaw of the same chamber. These
2 wires were attached to a force transducer or to a microme-
ter, respectively. An adjustable micrometer can pull the jaws
apart and stretch the artery between the 2 parallel wires. A
calibrated force transducer was used to measure the force,
with the output shown on a computer screen and printed in a
printer. Data were digitized and stored in the computer.
The Krebs solution had the following composition: Na+,
144 mmol/L; K+, 5.9 mmol/L; Ca2+, 2.5 mmol/L; Mg2+, 1.2
mmol/L; Cl–, 128.7 mmol/L; HCO3–, 25 mmol/L; SO42–, 1.2
mmol/L; H2PO4–, 1.2 mmol/L; and glucose, 11.0 mmol/L.
During normalization or relaxation studies, the solution was
aerated with a gas mixture of 95% oxygen and 5% carbon
dioxide at 37°C.
Two organ chamber arrangements in the same myograph
were run concurrently.
Normalization. The vessels were equilibrated for 45 min-
utes. The arterial rings were progressively stretched until the
passive transmural pressure reached 100 mm Hg, and then
the pressure was immediately released. The computerized
program determines the length-tension exponential curve for
each ring and gives the internal circumference and diameter
at a pressure of 100 mm Hg.17,18 The internal circumference
was then set to the value, estimated to be equivalent to 90%
of the circumference at a passive transmural pressure of 100
mm Hg.17 Only arterial rings in internal diameter of 200 to
450 m m at the pressure of 100 mm Hg were used in the pre-
sent study. The experiment was performed at the internal
diameter set up at 90% of the diameter (D0.9) under a pres-
sure of 100 mm Hg that is determined by the computer pro-
gram.17,18 The transluminal pressure, read from the computer
recording, at this diameter (D0.9) was between 55 and 70 mm
Hg in our experiment. The whole experiment was then per-
formed under this passive pressure (tension) on the vessel.
The isometric force at this setting is the “passive” or “resting”
force in the absence of constrictor tone. This method allows
one to set the vessel in vitro at a physiologic pressure and has
been shown to allow maximum tension development. In the
myograph (model 500A), the normalization procedure was
performed automatically. The diameter of the vessel at 100
mm Hg was determined by the length-tension curve during
the normalization procedure.
Protocol
Precontraction. The vessel was contracted with thrombox-
ane A2 mimetic U46619 (–8.5 log M). This dose was chosen
because, in our experiments, the median effective concentra-
tion EC50 for U46619-induced contraction was –8.78 ± 0.14
log M (n = 9 taken from 9 pig hearts), calculated from the
concentration-response curves in porcine coronary microar-
teries. U46619 at –8.5 log M caused a stable submaximal con-
traction of all rings.
EDHF-mediated (indomethacin and L-NNA–resistant)
relaxation. With the presence of the specific inhibitor for
cyclooxygenase indomethacin (7 m m) and the EDNO syn-
thase inhibitor NG-nitro-L-arginine (L-NNA, 300 m mol/L),
concentration-relaxation curves to bradykinin (–10 to –5.5
log M) were established when the U46619-induced contraction
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reached a plateau. This relaxation is considered to be related
to the EDHF function because EDNO and PGI2 are blocked
by indomethacin and L-NNA. The following protocol was
used.
EXPERIMENTAL GROUP I: PROFOUND HYPOTHERMIA (4°C)
GROUP IA. The washout time was 45 minutes. In cold Krebs
solution, 1 coronary arterial segment was cut into 2 pieces,
each 2 mm long. Two chambers of the duel-chamber myo-
graph was filled with either STS or Krebs solution (as the
control) at 4°C, respectively. Two rings were separately
mounted in the 2 chambers, and the myograph was then
placed in a refrigerator at 4°C for 4 hours. After storage for 4
hours, both rings were repeatedly washed with Krebs solution
of 37.0° ± 0.1°C that had been aerated with 95% oxygen and
5% carbon dioxide gas. The normalization procedure was
then performed, and 7 m mol/L indomethacin and 300 m mol/L
L-NNA were added to the chambers. Twenty minutes later,
the rings were precontracted with U46619 (–8.5 log M).
Cumulative concentration-response curves to bradykinin
were then established. The washout time (the time between
the washout of the cold STS or Krebs solution with warm
Krebs solution and the start of the concentration-relaxation
curve to bradykinin) was controlled at 45 minutes.
The composition of STS is Na+, 138 mmol/L; K+, 20
mmol/L; Ca2+, 2.7 mmol/L; Mg2+, 16 mmol/L; Cl–, 157
mmol/L; HCO3–, 8 mmol/L; lactate, 28 mmol/L; and pro-
caine, 1 mmol/L. The osmolarity is 370.
GROUP IB. The washout time was 90 minutes. In this group
of experiments, 2 arterial rings (2 mm long) obtained from
the same coronary arterial segment were immersed in either
STS or Krebs solution (as the control) at 4°C (in a refrigera-
tor) for 4 hours. The rings were then taken from the refriger-
ator, repeatedly washed with Krebs solution of 37° ± 0.1°C,
and mounted on the dual-chamber myograph. After equili-
bration for 20 minutes, the arterial rings were normalized.
Indomethacin (7 m mol/L) and L-NNA (300 m mol/L) were
added into the chambers. Twenty minutes later, the rings were
contracted with U46619 (–8.5 log M). Cumulative concentra-
tion-response curves to bradykinin were then established.
The washout time was controlled at 90 minutes.
EXPERIMENTAL GROUP II: MODERATE HYPOTHERMIA (22°C).
The arteries were incubated in either STS or Kreb’s solution
at room temperature (22°C). The exposure time to either STS
or Krebs solution (as the control) was 1 hour. Similar to that
mentioned earlier, the washout time was either 45 (group IIa)
or 90 minutes (group IIb).
In all experiments, only 1 concentration-relaxation curve
was obtained from each coronary ring. A mean concentra-
tion-relaxation curve was established from 7 to 9 rings in
each group of experiments. During the experiments, the
Krebs solution in the myograph chamber was continuously
bubbled with a gas mixture of 95% oxygen and 5% carbon
dioxide.
Data analysis. Mean maximal relaxation for each group
was calculated from the maximal relaxation of different rings
induced by bradykinin. The effective concentration of the
relaxation agent that caused 50% of maximal relaxation was
defined as EC50. The EC50 was determined from each concen-
tration-relaxation curve by a logistic, curve-fitting equation:
E = MAP/(AP + KP)
where E is response, M is maximal relaxation, A is con-
centration, K is EC50 concentration, and P is the slope para-
meter.18 From this fitted equation, the mean EC50 value ± the
SEM was calculated for each group.
Statistical analysis. All statistical analysis was performed
with SPSS software (SPSS, Inc, Chicago, Ill). The signifi-
cance of the difference between mean values was calculated
by the paired Student t test. Results are expressed as mean ±
SEM for observations of “n,” where “n” equals the number of
coronary arterial rings.
Drugs. Chemicals used and their sources were as follows:
bradykinin, L-NNA, and indomethacin (Sigma Chemical Co,
St Louis, Mo); U46619 (Cayman Chemical, Ann Arbor, Mich).
L-NNA (dissolved in distilled water) and indomethacin (dis-
solved in ethanol) were stored at 4°C. The solution of U46619
was held frozen until required. The STS was purchased from
David Bull Laboratories, Mulgrave, Victoria, Australia.
Results
Resting force. There was no significant difference
between the arteries exposed to STS and the control
with regard to the resting force after the various expo-
sure time at either temperature (P > .05). Table I gives
the details of the resting force in these microarteries.
Indomethacin (7 m mol/L) plus L-NNA (300 m mol/L)
induced a slow and slight increase in the basal tone of
coronary rings in all groups. It was 0.1 ± 0.1 mN (1 g
= 9.8 mN) vs 0.0 ± 0.1 mN in the control in group Ia (n
= 9; 95% confidence interval [CI], –0.5 to 0.3 mN; P =
.7), 0.5 ± 0.4 mN versus 0.6 ± 0.2 mN in the control in
group Ib (n = 7; 95% CI, –0.6 to 0.8 mN; P = .7), 0.6 ±
0.2 mN versus 0.8 ± 0.3 mN in the control in group IIa
(n = 8, 95% CI: –0.3 to 0.8 mN, P = .3), and 0.5 ± 0.2
mN versus 0.4 ± 0.2 mN in the control in group IIb (n =
8; 95% CI, –0.4 to 0.3 mN; P = .8).
U46619-induced contraction force. In all coronary
arterial rings, U46619 (–8.5 log M) induced a stable and
rapidly developing tension. This contraction force was
reduced by exposure to STS when measured at
washout for 45 minutes (group Ia, 9.5 ± 0.9 mN vs 14.6
± 0.7 mN; n = 8; 95% CI, 3.1 to 7.2 mN; P = .000;
group IIa, 8.9 ± 0.1 mN vs 13.0 ± 0.1 mN; n = 8; 95%
CI, 2.4 to 5.9 mN; P = .001). However, when washout
period was prolonged to 90 minutes, the contraction to
U46619 had no difference compared with the control
(group Ib, 14.1 ± 1.7 mN vs 14.6 ± 1.5 mN; n = 7; 95%
CI, –2.8 to 3.8 mN; P = .7; and group IIb, 13.3 ± 0.1
mN vs 13.5 ± 0.1 mN; n = 9; 95% CI, –2.2 to 2.5 mN;
P = 0.9). These results demonstrate that the smooth
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muscle contractility was impaired by exposure to STS
within 45 minutes after exposure but fully recovered
after 90 minutes (Fig 1).
Bradykinin-induced relaxation (percentage relax-
ation of U46619-induced precontraction) 
Experimental group I: profound hypothermia (4°C)
GROUP IA. With the presence of indomethacin (7
m mol/L) and L-NNA (300 m mol/L) in control rings
incubated in Krebs solution, bradykinin induced a max-
imal relaxation of 69.0% ± 5.3% with EC50 of –7.24 ±
0.09 log M (Fig 2). Treatment with STS at 4°C for 4
hours followed by washout for 45 minutes significant-
ly reduced bradykinin-induced maximal relaxation to
42.7% ± 3.5% (n = 9; 95% CI, 17.8% to 34.8%; P =
.000; Fig 2, A) although there was no change on the
EC50 (–7.12 ± 0.15 log M; n = 9; 95% CI, –0.22 to 0.46
log M; P = .44) (Table II).
GROUP IB. In contrast to the group Ia, treatment with
STS at 4°C for 4 hours followed by washout for 90
minutes did not change the bradykinin-induced relax-
ation (55.0% ± 7.2% vs 58.9% ± 4.6%; n = 7; 95% CI,
–11.0% to 18.9%; P = .5; Fig 2, B). Similarly, there was
no change on the EC50 (–7.23 ± 0.08 log M vs –7.35 ±
0.06 log M; n = 7; 95% CI, –0.12 to 0.38 log M; P =
.25). These results demonstrate that the bradykinin-
induced EDHF-mediated relaxation was impaired by
exposure to STS for 4 hours at 4°C within 45 minutes
after exposure but fully recovered after 90 minutes.
Experimental group II: moderate hypothermia
(22°C). The experiments were performed at room tem-
perature (22°C). The exposure time to either STS or
Krebs solution (as the control) was 1 hour. Similar to
that mentioned earlier, the washout time was either 45
(group IIa) or 90 (group IIb) minutes.
GROUP IIA. STS exposure at 22°C for 1 hour followed
by washout for 45 minutes had a profound effect on
bradykinin-induced maximal relaxation (12.3% ± 1.6%
vs 56.1% ± 4.4% in the control; n = 8; 95% CI, 36.0%
to 51.8%; P = .000; Fig 3, A) although the EC50 was not
significantly changed (–7.02 ± 0.17 log M vs –7.06 ±
0.13 log M; n = 8; 95% CI, –0.43 to 0.52 log M; P = .82)
(Table II).
GROUP IIB. The reducing effect of bradykinin-induced
relaxation seen in group Ia was eliminated by washout
for 90 minutes in group IIb (60.7% ± 4.3% vs 62.2% ±
5.2%; n = 8; 95% CI, –6.7% to 9.8%; P = .7; Fig 3, B)
with similar EC50 (–7.43 ± 0.08 log M vs –7.49 ± 0.05
log M; n = 8; 95% CI, –0.26 to 0.13 log M; P = .46).
Discussion
The present study, for the first time, demonstrates in
the coronary microarteries that the indomethacin-





Fig 1. A, Mean contraction force (mN) to U46619 (–8.5 log
M). Group I, after incubation with STS or Krebs solution
(control) at 4°C for 4 hours: group Ia (n = 9), washout for 45
minutes; group Ib (n = 7), washout for 90 minutes. Group II,
after incubation with STS or Krebs solution at 22°C for 1
hour: group IIa (n = 9), washout for 45 minutes; group IIb (n
= 8), washout for 90 minutes. Two artery rings were taken
from the same artery and allocated into the paired groups.
***P < .001. B, Endothelium-independent relaxation in
microarteries precontracted with U46619 (–8.5 log M) after
incubation with STS or Krebs solution (control) at 22°C for
1 hour. There were no differences between the 2 groups.
Table I. Resting force in coronary microarteries
Resting force (mN)
Group Control STS P 95% CI
Ia 5.5 ± 0.3 5.8 ± 0.6 .6 –1.41 to 0.86
Ib 5.7 ± 0.6 5.6 ± 0.7 1.0 –1.0 to 1.03
IIa 5.4 ± 0.6 5.2 ± 0.2 .7 –0.97 to 1.3
IIb 5.4 ± 0.4 5.3 ± 0.4 .6 –0.44 to 0.38
Values are means ± SE. Group I, after incubation with STS or Krebs solution
(control) at 4oC for 4 hours; group Ia, washout for 45 minutes; group Ib,
washout for 90 minutes (n = 7; paired t test). Two artery rings were taken from
the same artery and allocated into the paired groups. Group II, after incuba-
tion with STS or Krebs solution at 22oC for 1 hour; group IIa, washout for 45
minutes; group IIb, washout for 90 minutes after STS or Krebs solution at
22oC for 1 hour. Two artery rings were taken from the same artery and allo-
cated into the paired groups.
and L-NNA–resistant (EDHF-mediated), endothelial-
dependent relaxation is reduced after incubation with
STS at either moderate or profound hypothermia and
that this alteration of the EDHF-mediated relaxation is
dependent on the washout time. The effect is seen with-
in 45 minutes after the exposure but eliminated by
washout for 90 minutes.
Indomethacin- and L-NNA–resistant (EDHF-
mediated) endothelial function in the coronary
microarteries. Endothelial cells derive 3 major
EDRFs. Compared with EDNO and PGI2 that have
been well studied, the nature of EDHF has not been
finally identified, although most recently the
cytochrome P450–mono-oxygenase metabolite of
The Journal of Thoracic and
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Fig 2. Relaxation of the porcine coronary microarterial rings precontracted with –8.5 log M U46619 in response to
bradykinin (BK) with the presence of 7 m mol/L indomethacin (I) and 300 m mol/L L-NNA (L) at 45 (A) or 90 (B)
minutes of washout after exposure to STS or Krebs solution (control) at 4°C for 4 hours. Two artery rings were
taken from the same artery and allocated into the paired groups. Top panel (A and B), Mean concentration (log
M)-relaxation (% of contraction by U46619) curves for bradykinin. Vertical error bars are 1 SEM. A, *** P = .000
(n = 9; paired t test); B, P > .05 at all concentrations (n = 7). Bottom panel (A and B), Digitized traces of origi-
nal chart recordings from 2 rings taken from the same artery, showing the changes in isometric tension.
Table II. Maximal relaxation and EC50 values for bradykinin with the presence of indomethacin (7 µmol/L) and 
L-NNA (300 µmol/L)
Maximal relaxation (%) EC50 (log M)
Group Control STS P 95% CI Control STS P 95% CI
Ia (n = 9) 69.0 ± 5.3 42.7 ± 3.5 <.001 17.8 ~ 34.8 –7.24 ± 0.09 –7.12 ± 0.15 .44 –0.47 ~ 0.21
Ib (n = 7) 58.9 ± 4.6 55.0 ± 7.2 .5 –11.0 ~ 18.9 –7.35 ± 0.06 –7.23 ± 0.08 .25 –0.42 ~ 0.19
IIa (n = 8) 56.1 ± 4.4 12.3 ± 1.6 <.001 36.0 ~ 51.8 –7.06 ± 0.13 –7.02 ± 0.17 .82 –0.43 ~ 0.52
IIb (n = 8) 62.2 ± 5.2 60.7 ± 4.3 .7 –6.7 ~ 9.8 –7.49 ± 0.05 –7.43 ± 0.08 .46 –0.13 ~ 0.26
Values are means ± SE. Group I, after incubation with STS or Krebs solution (control) at 4˚C for 4 hours followed by a wash-out for 45 (group Ia) or 90 (group Ib)
minutes. Group II, after incubation with STS or Krebs solution at 22˚C for 1 hour followed by a wash-out for 45 (group IIa) or 90 (group IIb) minutes. Two artery
rings cut from the same artery were randomly allocated into the STS and control groups. The P values between paired groups were calculated with a paired t test.
arachidonic acid has been suggested to be EDHF.19-21
EDHF induces vascular smooth muscle relaxation by
hyperpolarization of the smooth muscle cells, which
may involve potassium (K+) channels.7,22-24 In contrast,
EDNO relaxes blood vessels through the cyclic guano-
sine monophosphate pathway. However, all of these
EDRFs are released in response to the increase of intra-
cellular (cytosolic free) calcium concentration in the
endothelial cell.6,7
Although the exact role of EDHF in regulating vas-
cular tone and in the development of vascular diseases
is still unclear, there is evidence that shows that EDNO
and EDHF are 2 primary mechanisms of endothelium-
dependent relaxation.25,26 We have previously reported
that EDHF plays a role in large conductance coronary
arteries.7,14-16 It has been suggested that EDHF plays an
even more important role in the regulation of the vas-
cular tone in microcirculation than in the large conduc-
tance arteries.8 In the present study, all experiments
were performed in the presence of the inhibitors of
EDNO and PGI2 (L-NNA and indomethacin) and there-
fore the bradykinin-induced relaxation is EDHF medi-
ated. We have previously reported that this relaxation is
linked with a membrane hyperpolarization in the coro-
nary conductance arteries16 and in microarteries.27 In
our experiments, the EDHF-stimulus bradykinin
induced 62.2% relaxation of the U46619-induced pre-
contraction, which reveals the role of EDHF in the reg-
ulation of the tone in the microarteries. Studies have
also shown that EDHF may back up or enhance the
relaxing action of EDNO, particularly when EDNO-
mediated relaxation is impaired28 as seen in some
pathologic status such as hypercholesterolemia, hyper-
tension, and diabetes mellitus.28 It may be true that in
the coronary microcirculation during ischemia and
reperfusion period, when the EDNO mechanism is
impaired,29 the EDHF-mechanism may play an impor-
tant role in regulating the coronary circulation.
EDHF-related relaxation after STS exposure and
possible mechanism. The effect of STS on the EDHF-




Fig 3. Relaxation of the porcine coronary microarterial rings precontracted with –8.5 log M U46619 in response to
bradykinin (BK) with the presence of 7 m mol/L indomethacin (I) and 300 m mol/L L-NNA (L) at 45 (A) or 90 (B)
minutes of washout after exposure to STS or Krebs solution (control) at 22°C for 1 hours. Two artery rings were
taken from the same artery and allocated into the paired groups. Top panel (A and B), Mean concentration (log
M)- relaxation (% of contraction by U46619) curves for bradykinin. Vertical error bars are 1 SEM. A, *** P = .000
(n = 8; paired t test); B, P > .05 at all concentrations (n = 8). Bottom panel (A and B), Digitized traces of origi-
nal chart recordings from 2 rings taken from the same artery, showing the changes in isometric tension.
mediated endothelial function is shown by the reduced
relaxation induced by bradykinin after exposure to STS
under profound hypothermia for 4 hours (group Ia) or
under moderate hypothermia for 1 hour (group IIa),
followed by washout for 45 minutes. These results
clearly demonstrate that, during the initial reperfusion
period, the EDHF-mediated relaxation in the microves-
sels is altered. We have previously reported that hyper-
kalemia damages the EDHF-mediated relaxation.7,14-16
Because STS is hyperkalemic (20 mmol/L K+), this
alteration is most likely related to the high K+.
Hyperkalemia reduces the EDHF-mediated relaxation
through the prolonged partial membrane depolarization
and affecting K-channels.14-16 This is also the likely
mechanism in the microvessels.
Effect of washout time on EDHF-related relax-
ation. We previously observed that, as mentioned, the
reduced EDHF-mediated relaxation is related to the
prolonged partial depolarization of the smooth muscle
membrane potential.14-16 Logically, such an effect may
be possibly reduced with prolonged washout time. We
therefore designed 2 different washout periods to
examine the EDHF-mediated relaxation. In this study,
we are able to support our hypothesis because, in our
experiments, it was demonstrated that with a prolonged
washout time (90 minutes) the effect of STS on the
EDHF-mediated relaxation was eliminated. However,
in cardiac operations, the first 45-minute reperfusion
period is probably the most critical time when the heart
is just resuscitated from ischemia as the result of total
arrest. Coronary dysfunction during this period may
predispose the heart to reduced myocardial perfusion
that is detrimental to the myocardial function.
Contractility of coronary artery after exposure to
STS. Under both profound and moderate hypothermia,
after exposure to STS, the contraction to U46619 was
reduced (Fig 1). This suggests that the coronary artery
is still at a partially plegic status at 45 minutes after
exposure to STS. Similar to the EDHF-mediated relax-
ation, the reduced contraction was fully recovered after
90 minutes. This shows that the reduced contraction
after exposure to STS is also time dependent.
Clinical implications. The present study suggests
that the EDHF-mediated endothelial function in the
coronary microarteries is reduced after incubation with
STS for either 4 hours at 4°C or 1 hour at 22°C. This
effect is seen within the initial 45-minute reperfusion
period and is eliminated at 90 minutes. Therefore dur-
ing the initial reperfusion period, the altered EDHF-
mediated relaxation in microcirculation may cause
coronary endothelial dysfunction and have a detrimen-
tal effect on the myocardial perfusion.
Moderate hypothermia is commonly used in cardiac
operations and 4-hour cold (4°C ) storage with STS is
used for the donor heart preservation for transplanta-
tion operations. Therefore the present study has strong
clinical implications with regard to the coronary dys-
function in the microcirculation in cardiac operations
and heart transplantation.
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